- Motley Fool•5 hours ago
It only took four drugs to do it.
- American City Business Journals•3 days ago
Curt Sprouse, the CEO of Ipswich-based consulting firm EurekaConnect, has organized a series of workshops in recent years where scientists are trained on how to translate discoveries in the lab into commercial treatments — a vexing problem facing local biotechs. Now Sprouse is looking to expand the program, called the Institute for Biomedical Entrepreneurship, into Europe. In an interview, he said that the group plans to host an event in April at Erasmus University in the Netherlands.
- Motley Fool•3 days ago
Carl Icahn has reportedly bought shares in this big-cap biopharma, but Bristol-Myers Squibb might be too big and costly to win an acquirer.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Bid||42.00 x 500|
|Ask||43.50 x 1000|
|Day's Range||42.26 - 42.83|
|52 Week Range||36.81 - 44.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.86|
|Dividend & Yield||1.66 (3.91%)|
|1y Target Est||N/A|